blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2668155

EP2668155 - NEW ARYL-BENZOCYCLOALKYL AMIDE DERIVATIVES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  02.10.2015
Database last updated on 14.09.2024
Most recent event   Tooltip12.10.2018Lapse of the patent in a contracting state
New state(s): AL
published on 14.11.2018  [2018/46]
Applicant(s)For all designated states
F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel / CH
[N/P]
Former [2013/49]For all designated states
F.Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel / CH
Inventor(s)01 / AEBI, Johannes
Im Kugelfang 27
CH-4102 Binningen / CH
02 / BINGGELI, Alfred
Im Kugelfang 50
CH-4102 Binningen / CH
03 / HERTEL, Cornelia
Hinter den Gaerten 15
CH-4225 Brislach / CH
04 / KONKAR, Anish Ashok
Oberwilerstrasse 51
CH-4102 Binningen / CH
05 / KUEHNE, Holger
Albert-Richter-Strasse 2
79540 Loerrach / DE
06 / KUHN, Bernd
Hinterlindenweg 26a
CH-4153 Reinach BL / CH
07 / MAERKI, Hans P.
Seltisbergerstrasse 75
CH-4059 Basel / CH
08 / WANG, Haiyan
Brennerstrasse 54
CH-4123 Allschwil / CH
 [2013/49]
Representative(s)Salud, Carlos E.
F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel / CH
[2014/48]
Former [2013/49]Salud, Carlos E.
F. Hoffmann-La Roche AG Grenzacherstrasse 124
4070 Basel / CH
Application number, filing date12702199.618.01.2012
WO2012EP50667
Priority number, dateEP2011015189024.01.2011         Original published format: EP 11151890
[2013/49]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2012101011
Date:02.08.2012
Language:EN
[2012/31]
Type: A2 Application without search report 
No.:EP2668155
Date:04.12.2013
Language:EN
The application published by WIPO in one of the EPO official languages on 02.08.2012 takes the place of the publication of the European patent application.
[2013/49]
Type: B1 Patent specification 
No.:EP2668155
Date:26.11.2014
Language:EN
[2014/48]
Search report(s)International search report - published on:EP20.09.2012
ClassificationIPC:C07D401/14, C07D413/14, C07D271/06, C07D305/08, C07D409/10, C07C237/24
[2014/31]
CPC:
C07C237/24 (EP,KR,US); A61K31/165 (KR); A61K31/4245 (KR);
A61P1/02 (EP); A61P1/04 (EP); A61P1/16 (EP);
A61P1/18 (EP); A61P11/00 (EP); A61P11/02 (EP);
A61P11/06 (EP); A61P11/08 (EP); A61P11/16 (EP);
A61P13/08 (EP); A61P13/10 (EP); A61P13/12 (EP);
A61P17/02 (EP); A61P17/04 (EP); A61P17/06 (EP);
A61P19/02 (EP); A61P19/08 (EP); A61P19/10 (EP);
A61P25/00 (EP); A61P25/04 (EP); A61P25/06 (EP);
A61P25/08 (EP); A61P25/16 (EP); A61P25/28 (EP);
A61P27/02 (EP); A61P29/00 (EP); A61P3/04 (EP);
A61P3/10 (EP); A61P31/04 (EP); A61P35/00 (EP);
A61P37/08 (EP); A61P7/10 (EP); A61P9/00 (EP);
A61P9/04 (EP); A61P9/10 (EP); C07D257/00 (KR);
C07D257/04 (EP,US); C07D271/06 (EP,US); C07D271/10 (EP,US);
C07D305/08 (EP,US); C07D311/00 (KR); C07D333/00 (KR);
C07D401/10 (EP,US); C07D401/14 (EP,US); C07D405/10 (EP,US);
C07D405/12 (EP,US); C07D409/10 (EP,US); C07D409/14 (EP,US);
C07D413/10 (EP,US); C07D413/12 (EP,US); C07D413/14 (EP,US);
C07C2602/02 (EP,US); C07C2602/08 (EP,US); C07C2602/10 (EP,US) (-)
Former IPC [2013/49]C07C237/24
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2013/49]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:NEUE ARYLBENZOCYCLOALKYLAMID-DERIVATE[2013/49]
English:NEW ARYL-BENZOCYCLOALKYL AMIDE DERIVATIVES[2013/49]
French:NOUVEAUX DÉRIVÉS D'ARYLBENZOCYCLOALKYLAMIDES[2013/49]
Entry into regional phase26.08.2013National basic fee paid 
26.08.2013Designation fee(s) paid 
26.08.2013Examination fee paid 
Examination procedure26.08.2013Examination requested  [2013/49]
15.04.2014Amendment by applicant (claims and/or description)
08.07.2014Communication of intention to grant the patent
15.10.2014Fee for grant paid
15.10.2014Fee for publishing/printing paid
15.10.2014Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  08.07.2014
Opposition(s)27.08.2015No opposition filed within time limit [2015/45]
Fees paidRenewal fee
08.01.2014Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU18.01.2012
AL26.11.2014
AT26.11.2014
BG26.11.2014
CY26.11.2014
CZ26.11.2014
DK26.11.2014
EE26.11.2014
FI26.11.2014
HR26.11.2014
LT26.11.2014
LV26.11.2014
MC26.11.2014
MK26.11.2014
MT26.11.2014
NL26.11.2014
PL26.11.2014
RO26.11.2014
RS26.11.2014
SE26.11.2014
SI26.11.2014
SK26.11.2014
SM26.11.2014
IE18.01.2015
LU18.01.2015
BE31.01.2015
NO26.02.2015
GR27.02.2015
IS26.03.2015
PT26.03.2015
[2018/46]
Former [2018/31]HU18.01.2012
AT26.11.2014
BG26.11.2014
CY26.11.2014
CZ26.11.2014
DK26.11.2014
EE26.11.2014
FI26.11.2014
HR26.11.2014
LT26.11.2014
LV26.11.2014
MC26.11.2014
MK26.11.2014
MT26.11.2014
NL26.11.2014
PL26.11.2014
RO26.11.2014
RS26.11.2014
SE26.11.2014
SI26.11.2014
SK26.11.2014
SM26.11.2014
IE18.01.2015
LU18.01.2015
BE31.01.2015
NO26.02.2015
GR27.02.2015
IS26.03.2015
PT26.03.2015
Former [2017/39]HU18.01.2012
AT26.11.2014
BG26.11.2014
CY26.11.2014
CZ26.11.2014
DK26.11.2014
EE26.11.2014
FI26.11.2014
HR26.11.2014
LT26.11.2014
LV26.11.2014
MC26.11.2014
MT26.11.2014
NL26.11.2014
PL26.11.2014
RO26.11.2014
RS26.11.2014
SE26.11.2014
SI26.11.2014
SK26.11.2014
SM26.11.2014
IE18.01.2015
LU18.01.2015
BE31.01.2015
NO26.02.2015
GR27.02.2015
IS26.03.2015
PT26.03.2015
Former [2017/03]AT26.11.2014
CY26.11.2014
CZ26.11.2014
DK26.11.2014
EE26.11.2014
FI26.11.2014
HR26.11.2014
LT26.11.2014
LV26.11.2014
MC26.11.2014
MT26.11.2014
NL26.11.2014
PL26.11.2014
RO26.11.2014
RS26.11.2014
SE26.11.2014
SI26.11.2014
SK26.11.2014
IE18.01.2015
LU18.01.2015
NO26.02.2015
GR27.02.2015
IS26.03.2015
PT26.03.2015
Former [2016/12]AT26.11.2014
CY26.11.2014
CZ26.11.2014
DK26.11.2014
EE26.11.2014
FI26.11.2014
HR26.11.2014
LT26.11.2014
LV26.11.2014
MC26.11.2014
NL26.11.2014
PL26.11.2014
RO26.11.2014
RS26.11.2014
SE26.11.2014
SI26.11.2014
SK26.11.2014
IE18.01.2015
LU18.01.2015
NO26.02.2015
GR27.02.2015
IS26.03.2015
PT26.03.2015
Former [2016/07]AT26.11.2014
CY26.11.2014
CZ26.11.2014
DK26.11.2014
EE26.11.2014
FI26.11.2014
HR26.11.2014
LT26.11.2014
LV26.11.2014
MC26.11.2014
NL26.11.2014
PL26.11.2014
RO26.11.2014
RS26.11.2014
SE26.11.2014
SK26.11.2014
IE18.01.2015
LU18.01.2015
NO26.02.2015
GR27.02.2015
IS26.03.2015
PT26.03.2015
Former [2015/43]AT26.11.2014
CY26.11.2014
CZ26.11.2014
DK26.11.2014
EE26.11.2014
FI26.11.2014
HR26.11.2014
LT26.11.2014
LV26.11.2014
MC26.11.2014
NL26.11.2014
PL26.11.2014
RO26.11.2014
RS26.11.2014
SE26.11.2014
SK26.11.2014
LU18.01.2015
NO26.02.2015
GR27.02.2015
IS26.03.2015
PT26.03.2015
Former [2015/39]AT26.11.2014
CY26.11.2014
CZ26.11.2014
DK26.11.2014
EE26.11.2014
FI26.11.2014
HR26.11.2014
LT26.11.2014
LV26.11.2014
NL26.11.2014
PL26.11.2014
RO26.11.2014
RS26.11.2014
SE26.11.2014
SK26.11.2014
LU18.01.2015
NO26.02.2015
GR27.02.2015
IS26.03.2015
PT26.03.2015
Former [2015/37]AT26.11.2014
CY26.11.2014
CZ26.11.2014
DK26.11.2014
EE26.11.2014
FI26.11.2014
HR26.11.2014
LT26.11.2014
LV26.11.2014
NL26.11.2014
PL26.11.2014
RO26.11.2014
RS26.11.2014
SE26.11.2014
SK26.11.2014
NO26.02.2015
GR27.02.2015
IS26.03.2015
PT26.03.2015
Former [2015/36]AT26.11.2014
CY26.11.2014
CZ26.11.2014
DK26.11.2014
EE26.11.2014
FI26.11.2014
HR26.11.2014
LT26.11.2014
LV26.11.2014
NL26.11.2014
RO26.11.2014
RS26.11.2014
SE26.11.2014
NO26.02.2015
GR27.02.2015
IS26.03.2015
PT26.03.2015
Former [2015/35]AT26.11.2014
CY26.11.2014
DK26.11.2014
EE26.11.2014
FI26.11.2014
HR26.11.2014
LT26.11.2014
LV26.11.2014
NL26.11.2014
RS26.11.2014
SE26.11.2014
NO26.02.2015
GR27.02.2015
IS26.03.2015
PT26.03.2015
Former [2015/26]AT26.11.2014
CY26.11.2014
FI26.11.2014
HR26.11.2014
LT26.11.2014
LV26.11.2014
NL26.11.2014
RS26.11.2014
SE26.11.2014
NO26.02.2015
GR27.02.2015
IS26.03.2015
PT26.03.2015
Former [2015/25]AT26.11.2014
FI26.11.2014
HR26.11.2014
LT26.11.2014
LV26.11.2014
NL26.11.2014
RS26.11.2014
SE26.11.2014
NO26.02.2015
GR27.02.2015
IS26.03.2015
PT26.03.2015
Former [2015/24]FI26.11.2014
HR26.11.2014
LT26.11.2014
LV26.11.2014
NL26.11.2014
RS26.11.2014
SE26.11.2014
NO26.02.2015
GR27.02.2015
IS26.03.2015
PT26.03.2015
Former [2015/23]FI26.11.2014
LT26.11.2014
NL26.11.2014
NO26.02.2015
IS26.03.2015
PT26.03.2015
Former [2015/22]LT26.11.2014
NO26.02.2015
PT26.03.2015
Former [2015/21]LT26.11.2014
NO26.02.2015
Former [2015/20]LT26.11.2014
Cited inInternational search[A]WO2004019868  (MERCK & CO INC [US], et al) [A] 1-69 * the whole document *;
 [A]WO2010097374  (BOEHRINGER INGELHEIM INT [DE], et al) [A] 1-69 * the whole document *;
 [A]WO03097610  (PHARMACIA ITALIA SPA [IT], et al) [A] 1-69 * the whole document *
by applicant   - GOODMAN; GILMAN'S, The Pharmacological Basis of Therapeutics, MACMILLAN PUBL. COMPANY, (1985), page 35
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.